Cidara Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cidara Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2014 to Q3 2024.
  • Cidara Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 7.05M shares, a 92.2% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 7.05M -83.4M -92.2% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 4.57M -85.7M -94.9% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 4.56M -85.5M -94.9% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 4.53M -67.9M -93.7% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 90.4M +19.2M +27% Sep 30, 2023 10-K 2024-04-22
Q2 2023 90.3M +21M +30.3% Jun 30, 2023 10-K 2024-04-22
Q1 2023 90M +21M +30.4% Mar 31, 2023 10-K 2024-04-22
Q4 2022 72.5M +4.61M +6.79% Dec 31, 2022 10-K 2024-04-22
Q3 2022 71.2M +21.6M +43.4% Sep 30, 2022 10-K 2024-04-22
Q2 2022 69.2M +19.7M +39.9% Jun 30, 2022 10-K 2024-04-22
Q1 2022 69M +20.8M +43% Mar 31, 2022 10-K 2024-04-22
Q4 2021 67.9M +23M +51.2% Dec 31, 2021 10-K 2023-03-23
Q3 2021 49.6M +5.69M +12.9% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 49.5M +7.49M +17.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 48.3M +7.73M +19.1% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 44.9M +11M +32.6% Dec 31, 2020 10-K 2022-03-07
Q3 2020 43.9M +10.9M +33.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 42M +15.3M +57% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 40.6M +13.9M +52.2% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 33.8M +6.02M +21.7% Dec 31, 2019 10-K 2021-02-25
Q3 2019 33M +5.25M +18.9% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 26.8M -910K -3.29% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 26.6M +6.11M +29.7% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 27.8M +7.29M +35.5% Dec 31, 2018 10-K 2020-03-04
Q3 2018 27.8M +10.9M +64.5% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 27.7M +10.8M +64.2% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 20.5M +3.73M +22.2% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 20.5M +3.75M +22.4% Dec 31, 2017 10-K 2019-02-28
Q3 2017 16.9M +2.95M +21.2% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 16.9M +2.96M +21.3% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 16.8M +2.96M +21.4% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 16.8M +2.99M +21.7% Dec 31, 2016 10-K 2018-02-27
Q3 2016 13.9M +220K +1.6% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 13.9M +302K +2.22% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 13.8M +12.7M +1107% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 13.8M +12.7M +1117% Dec 31, 2015 10-K 2017-03-15
Q3 2015 13.7M Sep 30, 2015 10-Q 2015-11-16
Q2 2015 13.6M Jun 30, 2015 10-Q 2015-08-11
Q1 2015 1.15M Mar 31, 2015 10-Q 2015-05-21
Q4 2014 1.13M Dec 31, 2014 10-K 2016-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.